The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oral Live Cholera Vaccines-Global Market Insights and Sales Trends 2024
Synopsis
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
The global Oral Live Cholera Vaccines market size is expected to reach US$ 143.7 million by 2029, growing at a CAGR of 7.0% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Live Cholera Vaccines in various end use industries. The expanding demands from the Prevention and Emergency Response, are propelling Oral Live Cholera Vaccines market. Euvichol- Plus, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the DUKORAL segment is estimated at % CAGR for the next seven-year period.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Live Cholera Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Live Cholera Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Live Cholera Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Live Cholera Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Live Cholera Vaccines covered in this report include PaxVax, Sanofi, Valneva, EuBiologics, Shanghai United Cell Biotechnology and Vabiotech, etc.
The global Oral Live Cholera Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
PaxVax
Sanofi
Valneva
EuBiologics
Shanghai United Cell Biotechnology
Vabiotech
Global Oral Live Cholera Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Live Cholera Vaccines market, Segment by Type:
Euvichol- Plus
DUKORAL
Shanchol
Others
Global Oral Live Cholera Vaccines market, by Application
Prevention
Emergency Response
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oral Live Cholera Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oral Live Cholera Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
The global Oral Live Cholera Vaccines market size is expected to reach US$ 143.7 million by 2029, growing at a CAGR of 7.0% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Live Cholera Vaccines in various end use industries. The expanding demands from the Prevention and Emergency Response, are propelling Oral Live Cholera Vaccines market. Euvichol- Plus, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the DUKORAL segment is estimated at % CAGR for the next seven-year period.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Live Cholera Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Live Cholera Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Live Cholera Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Live Cholera Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Live Cholera Vaccines covered in this report include PaxVax, Sanofi, Valneva, EuBiologics, Shanghai United Cell Biotechnology and Vabiotech, etc.
The global Oral Live Cholera Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
PaxVax
Sanofi
Valneva
EuBiologics
Shanghai United Cell Biotechnology
Vabiotech
Global Oral Live Cholera Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Live Cholera Vaccines market, Segment by Type:
Euvichol- Plus
DUKORAL
Shanchol
Others
Global Oral Live Cholera Vaccines market, by Application
Prevention
Emergency Response
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oral Live Cholera Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oral Live Cholera Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Oral Live Cholera Vaccines Market Overview
1.1 Oral Live Cholera Vaccines Product Overview
1.2 Oral Live Cholera Vaccines Market Segment by Type
1.2.1 Euvichol- Plus
1.2.2 DUKORAL
1.2.3 Shanchol
1.2.4 Others
1.3 Global Oral Live Cholera Vaccines Market Size by Type
1.3.1 Global Oral Live Cholera Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Oral Live Cholera Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Oral Live Cholera Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Live Cholera Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Oral Live Cholera Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Oral Live Cholera Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Oral Live Cholera Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Oral Live Cholera Vaccines Sales Breakdown by Type (2018-2023)
2 Global Oral Live Cholera Vaccines Market Competition by Company
2.1 Global Top Players by Oral Live Cholera Vaccines Sales (2018-2023)
2.2 Global Top Players by Oral Live Cholera Vaccines Revenue (2018-2023)
2.3 Global Top Players by Oral Live Cholera Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Oral Live Cholera Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Live Cholera Vaccines Market Competitive Situation and Trends
2.5.1 Oral Live Cholera Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Live Cholera Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Live Cholera Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Oral Live Cholera Vaccines Market
2.8 Key Manufacturers Oral Live Cholera Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Live Cholera Vaccines Status and Outlook by Region
3.1 Global Oral Live Cholera Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oral Live Cholera Vaccines Historic Market Size by Region
3.2.1 Global Oral Live Cholera Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Oral Live Cholera Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Oral Live Cholera Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Oral Live Cholera Vaccines Forecasted Market Size by Region
3.3.1 Global Oral Live Cholera Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Oral Live Cholera Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Oral Live Cholera Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oral Live Cholera Vaccines by Application
4.1 Oral Live Cholera Vaccines Market Segment by Application
4.1.1 Prevention
4.1.2 Emergency Response
4.2 Global Oral Live Cholera Vaccines Market Size by Application
4.2.1 Global Oral Live Cholera Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Oral Live Cholera Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Oral Live Cholera Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Live Cholera Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Oral Live Cholera Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Oral Live Cholera Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Oral Live Cholera Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Oral Live Cholera Vaccines Sales Breakdown by Application (2018-2023)
5 North America Oral Live Cholera Vaccines by Country
5.1 North America Oral Live Cholera Vaccines Historic Market Size by Country
5.1.1 North America Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oral Live Cholera Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Oral Live Cholera Vaccines Sales in Value by Country (2018-2023)
5.2 North America Oral Live Cholera Vaccines Forecasted Market Size by Country
5.2.1 North America Oral Live Cholera Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Oral Live Cholera Vaccines Sales in Value by Country (2024-2029)
6 Europe Oral Live Cholera Vaccines by Country
6.1 Europe Oral Live Cholera Vaccines Historic Market Size by Country
6.1.1 Europe Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oral Live Cholera Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Oral Live Cholera Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Oral Live Cholera Vaccines Forecasted Market Size by Country
6.2.1 Europe Oral Live Cholera Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Oral Live Cholera Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Oral Live Cholera Vaccines by Region
7.1 Asia-Pacific Oral Live Cholera Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oral Live Cholera Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Oral Live Cholera Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Oral Live Cholera Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Live Cholera Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oral Live Cholera Vaccines Sales in Value by Region (2024-2029)
8 Latin America Oral Live Cholera Vaccines by Country
8.1 Latin America Oral Live Cholera Vaccines Historic Market Size by Country
8.1.1 Latin America Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oral Live Cholera Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Oral Live Cholera Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Oral Live Cholera Vaccines Forecasted Market Size by Country
8.2.1 Latin America Oral Live Cholera Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oral Live Cholera Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Oral Live Cholera Vaccines by Country
9.1 Middle East and Africa Oral Live Cholera Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Oral Live Cholera Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oral Live Cholera Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Oral Live Cholera Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Oral Live Cholera Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Live Cholera Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oral Live Cholera Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 PaxVax
10.1.1 PaxVax Company Information
10.1.2 PaxVax Introduction and Business Overview
10.1.3 PaxVax Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 PaxVax Oral Live Cholera Vaccines Products Offered
10.1.5 PaxVax Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Oral Live Cholera Vaccines Products Offered
10.2.5 Sanofi Recent Development
10.3 Valneva
10.3.1 Valneva Company Information
10.3.2 Valneva Introduction and Business Overview
10.3.3 Valneva Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Valneva Oral Live Cholera Vaccines Products Offered
10.3.5 Valneva Recent Development
10.4 EuBiologics
10.4.1 EuBiologics Company Information
10.4.2 EuBiologics Introduction and Business Overview
10.4.3 EuBiologics Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 EuBiologics Oral Live Cholera Vaccines Products Offered
10.4.5 EuBiologics Recent Development
10.5 Shanghai United Cell Biotechnology
10.5.1 Shanghai United Cell Biotechnology Company Information
10.5.2 Shanghai United Cell Biotechnology Introduction and Business Overview
10.5.3 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Products Offered
10.5.5 Shanghai United Cell Biotechnology Recent Development
10.6 Vabiotech
10.6.1 Vabiotech Company Information
10.6.2 Vabiotech Introduction and Business Overview
10.6.3 Vabiotech Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Vabiotech Oral Live Cholera Vaccines Products Offered
10.6.5 Vabiotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Live Cholera Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Live Cholera Vaccines Industrial Chain Analysis
11.4 Oral Live Cholera Vaccines Market Dynamics
11.4.1 Oral Live Cholera Vaccines Industry Trends
11.4.2 Oral Live Cholera Vaccines Market Drivers
11.4.3 Oral Live Cholera Vaccines Market Challenges
11.4.4 Oral Live Cholera Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Live Cholera Vaccines Distributors
12.3 Oral Live Cholera Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
